Join us in supporting the Breakthrough T1D Walk, New Hampshire 2024! As the leading global type 1 diabetes (T1D) research and advocacy organization, Breakthrough T1D has been instrumental in nearly every major T1D breakthrough in history. No organization does more to improve everyday life with T1D—from therapy development and access to expanding research, advocacy, and community support.
The Breakthrough T1D Walk is the world’s largest fundraising and community-building event for the T1D community. By participating in the Breakthrough T1D Walk, you will help create a movement to improve and change life with type 1 diabetes, advancing life-changing breakthroughs on the way to cures.
T1D is an autoimmune disease diagnosed in both children and adults, unrelated to diet or lifestyle. Managing T1D requires constant attention and action, even overnight. Despite a strict regimen, people with T1D can still experience dangerously high or low blood sugar levels that can lead to complications and, in extreme cases, be life-threatening.
Your contribution to the Breakthrough T1D Walk, New Hampshire 2024 will chart a path to cure, prevent, and better treat type 1 diabetes and its complications, ensuring global access to treatments.
Register today for the Breakthrough T1D Walk, New Hampshire 2024, and join us in taking action for the entire T1D community. If you are interested in volunteering please sign up here.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
